1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
69684BC7FB2BDC21C852583200051EDEA
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/9684BC7FB2BDC21C852583200051EDEA!OpenDocument
18
19OpenDocument
2034.237.76.91
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Managed Care Payer Market Research

Document Excerpt: Outcomes-Based Contract Initiatives: Disrupting the High Cost of Prescription Medications

DB Image

ID: MD-629


Features:

13 Info Graphics

6 Data Graphics

70+ Metrics


Pages/Slides: 25


Published: 2018


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".


To return to the study abstract to purchase the full study - click here

This excerpt includes research findings and metrics from document #5529 "Outcomes-Based Contract Initiatives: Disrupting the High Cost of Prescription Medications".

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Health Care; Consumer Products


Companies Profiled:
Novartis; Bioverativ; Neos Therapeutics; Organogenisis; Janssen; UCB Pharma; AstraZeneca; GlaxoSmithKline ; Pfizer; LEO Pharma; Nestle

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.